CTL Immunotherapies Corporation, is a biopharmaceutical company and a leader in the development of advanced vaccines and diagnostics for treating cancer and chronic infections. The company has established operational capabilities in all areas of research and development, including a new state-of-the-art manufacturing unit to support clinical trial testing of the SYNCRHOVAX line of vaccine products.